In the past decade, extracellular vesicles (EVs) have emerged as a key cell-free strategy for
the treatment of a range of pathologies, including cancer, myocardial infarction, and …

Tetraspanins are transmembrane glycoproteins that have been shown increasing interest as
host factors in infectious diseases. In particular, they were implicated in the pathogenesis of …

Surface display technology is an emerging key player in presenting functional proteins for
targeted drug delivery and therapy. Although a number of technologies exist, a desirable …

Benefiting from the blooming interaction of nanotechnology and biotechnology, biosynthetic
cellular membrane vesicles (Bio‐MVs) have shown superior characteristics for therapeutic …

Exosomes are cell-derived nanovesicles that hold promise as living vehicles for intracellular
delivery of therapeutics to mammalian cells. This potential, however, is undermined by the …

Simple Summary Novel therapeutic targets are needed to improve treatments of aggressive
cancers and viral diseases. Tetraspanins represent an emerging class of anticancer targets …

Exosomes are cell–cell communicators emerging as a new paradigm for noninvasive
diagnosis and prognosis of treatment response. Exosomal tetraspanin proteins like CD63 …

One of the hallmarks of cancer is the ability to activate invasion and metastasis. Cancer
morbidity and mortality are largely related to the spread of the primary, localized tumour to …

Here, we describe data obtained from transcriptome profiling of human cell lines and
intestinal cells of a murine model upon exposure and colonization, respectively, with …

The tetraspanins constitute a conserved superfamily of four-span membrane proteins that
are widely distributed in multi-cellular organisms. A characteristic property of tetraspanins is …